RSS feed

Publications by Lars Retterstøl

29 publications found

Original articles

Dusanov S, Ruzzin J, Kiviranta H, Klemsdal TO, Retterstøl L, Rantakokko P, Airaksinen R, Djurovic S, Tonstad S (2018)
Associations between persistent organic pollutants and metabolic syndrome in morbidly obese individuals
Nutr Metab Cardiovasc Dis, 28 (7), 735-742
DOI 10.1016/j.numecd.2018.03.004, PubMed 29699815

Sitek JC, Kulseth MA, Rypdal KB, Skodje T, Sheng Y, Retterstøl L (2018)
Whole-exome sequencing for diagnosis of hereditary ichthyosis
J Eur Acad Dermatol Venereol, 32 (6), 1022-1027
DOI 10.1111/jdv.14870, PubMed 29444371

Bakke KA, Howlin P, Retterstøl L, Kanavin ØJ, Heiberg A, Nærland T (2018)
Effect of epilepsy on autism symptoms in Angelman syndrome
Mol Autism, 9, 2
DOI 10.1186/s13229-017-0185-1, PubMed 29340132

Lande A, Kroken M, Rabben K, Retterstøl L (2017)
Temple syndrome as a differential diagnosis to Prader-Willi syndrome: Identifying three new patients
Am J Med Genet A, 176 (1), 175-180
DOI 10.1002/ajmg.a.38533, PubMed 29159982

Møllersen L, Moldestad O, Rowe AD, Bjølgerud A, Holm I, Tveterås L, Klungland A, Retterstøl L (2016)
Effects of Anthocyanins on CAG Repeat Instability and Behaviour in Huntington's Disease R6/1 Mice
PLoS Curr, 8
DOI 10.1371/currents.hd.58d04209ab6d5de0844db7ef5628ff67, PubMed 27540492

Horn MA, Mikaelsen KB, Ferdinandusse S, Jørum E, Mellgren SI, Retterstøl L, Wanders RJ, Tallaksen CM (2015)
Mild phenotype in an adult male with X-linked adrenoleukodystrophy - case report
Clin Case Rep, 4 (2), 177-81
DOI 10.1002/ccr3.434, PubMed 26862418

Wangensteen T, Retterstøl L, Rødningen OK, Hjelmesaeth J, Aukrust P, Halvorsen B (2013)
De novo 19p13.2 microdeletion encompassing the insulin receptor and resistin genes in a patient with obesity and learning disability
Am J Med Genet A, 161A (6), 1480-6
DOI 10.1002/ajmg.a.35927, PubMed 23637016

Horn MA, Retterstøl L, Abdelnoor M, Skjeldal OH, Tallaksen CM (2013)
Adrenoleukodystrophy in Norway: high rate of de novo mutations and age-dependent penetrance
Pediatr Neurol, 48 (3), 212-9
DOI 10.1016/j.pediatrneurol.2012.12.007, PubMed 23419472

Wangensteen T, Akselsen H, Holmen J, Undlien D, Retterstøl L (2010)
A common haplotype in NAPEPLD is associated with severe obesity in a Norwegian population-based cohort (the HUNT study)
Obesity (Silver Spring), 19 (3), 612-7
DOI 10.1038/oby.2010.219, PubMed 20885390

Wangensteen T, Egeland T, Akselsen H, Holmen J, Undlien D, Retterstøl L (2010)
FTO genotype and weight gain in obese and normal weight adults from a Norwegian population based cohort (the HUNT study)
Exp Clin Endocrinol Diabetes, 118 (9), 649-52
DOI 10.1055/s-0030-1249636, PubMed 20373279

van Walsem MR, Sundet K, Retterstøl L, Sundseth Ø (2009)
A double blind evaluation of cognitive decline in a Norwegian cohort of asymptomatic carriers of Huntington's disease
J Clin Exp Neuropsychol, 32 (6), 590-8
DOI 10.1080/13803390903337878, PubMed 19916101

Wangensteen T, Kolsgaard ML, Mattingsdal M, Joner G, Tonstad S, Undlien D, Retterstol L (2009)
Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway
Exp Clin Endocrinol Diabetes, 117 (6), 266-73
DOI 10.1055/s-0028-1102942, PubMed 19301229

Karlsen A, Retterstøl L, Laake P, Paur I, Bøhn SK, Sandvik L, Blomhoff R (2007)
Anthocyanins inhibit nuclear factor-kappaB activation in monocytes and reduce plasma concentrations of pro-inflammatory mediators in healthy adults
J Nutr, 137 (8), 1951-4
DOI 10.1093/jn/137.8.1951, PubMed 17634269

Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese G, Keogh JM, Lank E, Bottomley B, Lopez-Fernandez J, Ferraz-Amaro I, Dattani MT, Ercan O, Myhre AG, Retterstol L, Stanhope R, Edge JA, McKenzie S, Lessan N, Ghodsi M, De Rosa V, Perna F, Fontana S, Barroso I, Undlien DE, O'Rahilly S (2007)
Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor
N Engl J Med, 356 (3), 237-47
DOI 10.1056/NEJMoa063988, PubMed 17229951

Djurovic S, Berge KE, Birkenes B, Braaten Ø, Retterstøl L (2007)
The effect of red wine on plasma leptin levels and vasoactive factors from adipose tissue: a randomized crossover trial
Alcohol Alcohol, 42 (6), 525-8
DOI 10.1093/alcalc/agm056, PubMed 17670801

Retterstol L, Lyberg T, Aspelin T, Berg K (2006)
A twin study of nitric oxide levels measured by serum nitrite/nitrate
Twin Res Hum Genet, 9 (2), 210-4
DOI 10.1375/183242706776382464, PubMed 16611490

Retterstol L, Berge KE, Braaten Ø, Eikvar L, Pedersen TR, Sandvik L (2005)
A daily glass of red wine: does it affect markers of inflammation?
Alcohol Alcohol, 40 (2), 102-5
DOI 10.1093/alcalc/agh132, PubMed 15642722

Retterstol L, Eikvar L, Berg K (2003)
A twin study of C-Reactive Protein compared to other risk factors for coronary heart disease
Atherosclerosis, 169 (2), 279-82
DOI 10.1016/s0021-9150(03)00192-8, PubMed 12921979

Retterstol L, Paus B, Bohn M, Bakken A, Erikssen J, Malinow MR, Berg K (2003)
Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction: a 10-year follow-up study
J Intern Med, 253 (3), 284-92
DOI 10.1046/j.1365-2796.2003.01096.x, PubMed 12603495

Mosdøl A, Christensen B, Retterstøl L, Thelle DS (2002)
Induced changes in the consumption of coffee alter ad libitum dietary intake and physical activity level
Br J Nutr, 87 (3), 261-6
DOI 10.1079/BJNBJN2001506, PubMed 12064335

Retterstol L, Eikvar L, Bohn M, Bakken A, Erikssen J, Berg K (2002)
C-reactive protein predicts death in patients with previous premature myocardial infarction--a 10 year follow-up study
Atherosclerosis, 160 (2), 433-40
DOI 10.1016/s0021-9150(01)00595-0, PubMed 11849668

Retterstol L, Djurovic S, Bohn M, Bakken A, Erikssen J, Berg K (2001)
Plasma N-terminal pro-atrial natriuretic peptide predicts death after premature myocardial infarction, but not as well as radionuclide ejection fraction. A ten-year follow-up study
Scand Cardiovasc J, 35 (6), 373-8
DOI 10.1080/14017430152754853, PubMed 11837516

Christensen B, Mosdol A, Retterstol L, Landaas S, Thelle DS (2001)
Abstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol--a randomized controlled trial
Am J Clin Nutr, 74 (3), 302-7
DOI 10.1093/ajcn/74.3.302, PubMed 11522552

Retterstol L, Kierulf P, Pedersen JC, Bohn M, Bakken A, Erikssen J, Berg K (2001)
Plasma fibrinogen level and long-term prognosis in Norwegian middle-aged patients with previous myocardial infarction. A 10 year follow-up study
J Intern Med, 249 (6), 511-8
DOI 10.1046/j.1365-2796.2001.00837.x, PubMed 11422657

Christensen B, Landaas S, Stensvold I, Djurovic S, Retterstøl L, Ringstad J, Berg K, Thelle DS (1999)
Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction
Atherosclerosis, 147 (2), 317-26
DOI 10.1016/s0021-9150(99)00202-6, PubMed 10559518

Retterstøl L, Svane S (1995)
[Acute psychosis--an unusual clinical manifestation of primary hyperparathyroidism]
Tidsskr Nor Laegeforen, 115 (29), 3623-4
PubMed 8539717

Review articles

Wangensteen T, Undlien D, Tonstad S, Retterstøl L (2005)
[Genetic causes of obesity]
Tidsskr Nor Laegeforen, 125 (22), 3090-3
PubMed 16299561

Other articles

Horn MA, Retterstøl L, Abdelnoor M, Skjeldal OH, Tallaksen CM (2014)
Age-dependent penetrance among females with X-linked adrenoleukodystrophy
Brain, 138 (Pt 2), e325
DOI 10.1093/brain/awu232, PubMed 25149409

Theses

Retterstøl L (2002)
Novel indicators of prognosis after premature myocardial infarction: a ten year follow-up study of patients who have reached astable stage of coronary heart disease
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 13, 1 b. (flere pag.)
BIBSYS 020700563, ISBN 82-8080-003-4